Search

everythinglearnresearchcommunity

for

Search:↓

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

GI197111X is best dissolved in Capmul MCM for trials.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Ritlecitinib works well and is safe for treating alopecia areata.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Upadacitinib may effectively treat resistant lichen planopilaris.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

SH-340 may improve skin barrier and help treat atopic dermatitis.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

CS12192 effectively treats alopecia areata with better safety than current options.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Tacrolimus is a better option than cyclosporine due to fewer side effects.